EMA — authorised 24 March 2020
- Marketing authorisation holder: Novartis Europharm Limited
- Status: approved
🇪🇺 Scemblix in European Union
EMA authorised Scemblix on 24 March 2020
Marketing authorisation
Scemblix in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Scemblix approved in European Union?
Yes. EMA authorised it on 24 March 2020.
Who is the marketing authorisation holder for Scemblix in European Union?
Novartis Europharm Limited holds the EU marketing authorisation.